Form 4: CTS Director Robert Profusek Receives Stock Grant

CTS Corp. Director Robert Profusek was granted 3,500 restricted stock units, increasing his direct beneficial ownership to 101,742 shares.

Summary

• Robert Profusek, a Director of CTS Corp. (CTS), acquired 3,500 shares of common stock.
• The transaction occurred on November 6, 2025, and involved restricted stock units (RSUs) granted at a price of $0.
• These RSUs will vest 100% on the first anniversary of the grant date, contingent upon Mr. Profusek's continued service as a director.
• Following this transaction, Mr. Profusek directly beneficially owns 101,742 shares of CTS common stock.
• Additionally, Mr. Profusek indirectly beneficially owns 1,800 shares of common stock through his spouse.

Sentiment

Score: 7

Explanation: The grant of restricted stock units to a director is generally a positive event as it aligns the director's financial interests with the company's long-term performance and shareholder value, indicating continued commitment.

Positives

• The grant of 3,500 restricted stock units to a director aligns management's interests with those of shareholders, as vesting is contingent on continued service and future stock performance.

Future Outlook

The 3,500 restricted stock units granted to Director Robert Profusek are scheduled to vest 100% on the first anniversary of the grant date, provided he continues his service as a director through that date.

Industry Context

This transaction represents a routine compensation event for a director of a publicly traded company, common across various industries to incentivize long-term commitment and align leadership interests with shareholder value.

Stakeholder Impact

• Shareholders: The grant aligns the director's interests with shareholders, potentially fostering decisions that enhance long-term company value.
• Employees: No direct impact on general employees is indicated by this filing.

Next Steps

• The 3,500 restricted stock units are expected to vest on the first anniversary of the grant date (November 6, 2026), subject to Robert Profusek's continued service as a director.

Key Dates

Recommendation

This Form 4 reports a routine insider transaction involving a stock grant to a director, which is a common compensation practice. It does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transaction primarily serves to align the director's interests with shareholders.

Keywords

CTS, Form 4, Insider Transaction, Stock Grant, Director Compensation, Restricted Stock Units, Beneficial Ownership